Federal award
ORTHO-CLINICAL DIAGNOSTICS, INC
W91YTZ21P0112
Contract
Obligated and Ceiling
- Obligated (net)
- $1,712,390.04
- Ceiling (potential value, not spending)
- $1,712,390.04
- Current value
- $1,712,390.04
- Gross positive obligations
- $1,740,778.65
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ORTHO-CLINICAL DIAGNOSTICS, INC · JG5JF2JQJ121
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ORTHO-CLINICAL DIAGNOSTICS, INC. · S2FCVS5TWDZ2
- Awarding agency
- Department of War · sub-agency 2100 · office W91YTZ
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- W91YTZ21P0112
- Award type code
- B
- Actions
- 12 · Jun 30, 2021 to Jun 5, 2026
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History12
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jun 5, 2026 | FY2026 | P00011 | M | $0.00 | — |
| Oct 7, 2024 | FY2025 | P00010 | C | $434,959.07 | — |
| Apr 26, 2024 | FY2024 | P00009 | G | $0.00 | — |
| Nov 17, 2023 | FY2024 | P00008 | C | −$28,388.61 | — |
| Nov 2, 2023 | FY2024 | P00007 | B | $1,511.05 | — |
| Oct 20, 2023 | FY2024 | P00006 | B | $434,959.07 | — |
| May 23, 2023 | FY2023 | P00005 | G | $0.00 | — |
| Oct 14, 2022 | FY2023 | P00004 | C | $422,174.73 | — |
| Sep 7, 2022 | FY2022 | P00003 | B | $25,000.00 | — |
| Jun 6, 2022 | FY2022 | P00002 | G | $0.00 | — |
| Oct 26, 2021 | FY2022 | P00001 | C | $422,174.73 | — |
| Jun 30, 2021 | FY2021 | 0 | — | $0.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.